Home arrow Home

Announcements

  • HIV Forum congrulates Nina Mani on her new position at FDA
    • MAY-17-13 Please join the Forum in congratulating Nina Mani on an exciting new career move. Nina is leaving the Forum, but she is not going far – starting June 3 she will join the FDA Center for Drug Evaluation Research, Division of Antiviral Products. That we will miss her is the understatement of the century. But the offer to join our colleagues at the FDA as a project manager presented a phenomenal opportunity – an excellent fit for her career path. We congratulate Jeff, Kim, Jules and Patrick on an excellent choice! We imagine that many of you will have the pleasure of interacting with her in her new capacity.
  • HIV Forum Mourns the Passing of Executive Committee Member Dr. Jim Goodrich
    • MAY-10-13 We are saddened to report the death of James Goodrich, PhD, MD of ViiV Healthcare, a member of the Forum’s Executive Committee. Jim passed away unexpectedly last weekend and is survived by his wife, Carolyn and two teenage daughters. A memorial service for Jim will be held this summer on a date to be determined. Jim has been a considered and thoughtful participant on the Executive Committee. His desire to improve care for patients, direct approach and sense of humor will be missed. Please join us in keeping Jim’s family in our thoughts and prayers.
  • Art Reingold apointed to Advisory Council on Immunization Practices
    • MAY-06-13 Arthur Reingold, MD, professor of epidemiology and associate dean for research at the UC Berkeley School of Public Health, was appointed to the Advisory Committee on Immunization Practices (ACIP) by Secretary Kathleen Sebelius of the Department of Health and Human Services. Learn more>>>
  • HIV Forum Applauds Task Force Call for Routine HIV Testing of All Adults
    • MAY-01-13 On behalf of the HIV/AIDS community, the Forum for Collaborative HIV Research applauds the U.S. Preventive Services Task Force for acting to help the estimated 1.2 million Americans now living with HIV and especially the nearly one in five - an estimated 258,000 people - who don't know they are infected.
  • Task Force Calls for Routine HIV Testing for All Adults
    • APR-30-13 The USPSTF is calling for HIV screening for all Americans aged 15 to 65, regardless of whether they are considered to be at high risk, a change that may help lift some of the stigma associated with HIV testing. Read more >>

door-square
2012 Summit Program
2012_summit_logo_bluebox_-_copy
 
 

Monday November 26, 2012

05:00 PM

OPENING PLENARY
Welcome
Veronica Miller, Forum for Collaborative HIV Research
Kenneth H. Mayer, The Fenway Institute
John G. Bartlett, Johns Hopkins University School of Medicine

State of the Epidemics: Viral Hepatitis and HIV in the U.S.
Kevin Fenton, Centers for Disease Control and Prevention

HRSA and the National HIV/AIDS Strategy and Viral Hepatitis Action Plan
Sarah Linde-Feucht, Health Resources and Services Administration

KEYNOTE ADDRESS
Secretary Kathleen Sebelius, Department of Health and Human Services

 

 

 

07:00 PM

Dinner

Tuesday November 27, 2012

07:00 AM

Breakfast

08:00 AM

BREAKOUT SESSIONS
A. Routine and Expanded Testing: HIV Diagnostics and Testing
B. Prevention Models: Pre-Exposure Prophylaxis for HIV Prevention
C. Outcomes and Impact Evaluation: Surveillance, Observational Databases, and Cohorts
D. Access, Linkage and Retention in Care: Access to Care for Persons with HIV and Viral Hepatitis: Policy Forum

 
 
 
 

09:30 AM

Break

09:45 AM

BREAKOUT SESSIONS
A. Routine and Expanded Testing: HCV Diagnostics and Birth Cohort Testing
B. Prevention Models: Population Approaches to Prevention
C. Outcomes and Impact Evaluation: Clinical and cost-effectiveness research
D. Access, Linkage and Retention in Care: HCV Workforce Capacity: Models and the HCV Workforce

 
 
 
 

11:20 AM

AWARD PRESENTATION
2012 C. Everett Koop HIV/AIDS Public Health Leadership Award
Veronica Miller, Forum for Collaborative HIV Research
Anthony S. Fauci, National Institute of Allergy and Infectious Diseases
Representative Henry A. Waxman, U.S. House of Representatives

12:15 PM

Lunch

01:00 PM

AFTERNOON PLENARY
PANEL DISCUSSION: The Affordable Care Act, Opportunities and Challenges at the State and Local Level
Moderator:
Jeffrey S. Crowley, O'Neill Institute for National and Global Health Law, Georgetown Law
Panelists:
Steve Boswell, The Fenway Institute
Lynda Dee, AIDS Action Baltimore
Jennifer Kates, Kaiser Family Foundation
Donna Sweet, University of Kansas Medical Center

01:55 PM

BREAKOUT SESSIONS
A. Routine and Expanded Testing: Models for HIV and HCV Testing
Cross-Cutting Session: Viral Hepatitis and HIV Prevention, Diagnosis and Access to Care and Correctional Settings
C. Outcomes and Impact Evaluation: Outcomes and Epidemiology
D. Access, Linkage and Retention in Care: HIV Care and Treatment: Who are and Who will be the Providers?

 
 
 
 

03:15 PM

Break

03:30 PM

BREAKOUT SESSIONS
A. Routine and Expanded Testing: Testing Integration in the Primary Care Setting
B. Prevention Models: Focus on HIV Prevention for Most-At-Risk Populations
A. Routine and Expanded Testing: Policy Issues Affecting HIV and HCV Testing
D. Access, Linkage and Retention in Care: Care Models that Support Linkage and Retention in Care

 
 
 
 

05:00 PM

POSTER SESSION
Session A
Session B

 
 

07:00 PM

Dinner

08:00 PM

PERFORMANCE
THE MEDEA PROJECT: THEATER FOR INCARCERATED WOMEN

Wednesday November 28, 2012

07:00 AM

Breakfast

08:00 AM

RAPPORTEUR SESSION

09:10 AM

CLOSING PLENARY
Federal Response to the Viral Hepatitis and HIV Epidemics in the U.S.
Moderators: Henry Masur, National Institutes of Health Clinical Center, Kenneth H. Mayer, The Fenway Institute

The National HIV/AIDS Strategy at Two Years
Grant Colfax, Office of National AIDS Policy, The White House

Implementation of the Viral Hepatitis Action Plan
John Ward, Centers for Disease Control and Prevention

Monitoring the Impact of the NHAS and ACA on Improving HIV Care
Jennifer Kates, Kaiser Family Foundation

PANEL DISCUSSION: Federal Response
Grant Colfax, Office of National AIDS Policy, The White House
Jennifer Kates, Kaiser Family Foundation
John Ward, Centers for Disease Control and Prevention

 
 
 
 

10:15 AM

Break

10:30 AM

Treatment & Prevention: New Research Going Forward
Moderators: John G. Bartlett, Johns Hopkins University School of Medicine, Veronica Miller, Forum for Collaborative HIV Research

A New Look at Treatment as Prevention
Myron Cohen, University of North Carolina School of Medicine

Behavioral Economics: A Role in HIV and Viral Hepatitis Treatment and Prevention?
Kevin Volpp, Perelman School of Medicine, University of Pennsylvania

PANEL DISCUSSION:
Myron Cohen, University of North Carolina School of Medicine
Naresh Chand, National Institute on Drug Abuse
Henry Masur, National Institutes of Health Clinical Center
Daniel Raymond, Harm Reduction Coalition
David Thomas, Johns Hopkins Center for Global Health
Kevin Volpp, Perelman School of Medicine, University of Pennsylvania

 
 
 

11:45 AM

Closing Remarks
Kenneth H. Mayer, The Fenway Institute
John G. Bartlett, Johns Hopkins University School of Medicine
Veronica Miller, Forum for Collaborative HIV Research